NCT06899464View on ClinicalTrials.gov

Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

April 1, 2027

Conditions
Intracerebral HemorrhageHemorrhagic Stroke, IntracerebralHemorrhagic StrokeStroke
Interventions
DRUG

14-day Cerebrolysin treatment

14-day cerebrolysin treatment initiated within 6 hours of onset of stroke

OTHER

Standard of Care (SOC)

Standard of care treatment

All Listed Sponsors
lead

Cardinal Stefan Wyszynski University

OTHER